Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.600
-0.070 (-1.91%)
May 20, 2026, 9:31 AM EDT - Market open
Niagen Bioscience Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$14.67
Upside
+307.50%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +205.56% | May 11, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $10 | Strong Buy | Maintains | $13 → $10 | +177.78% | May 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +261.11% | Mar 31, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +261.11% | Mar 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $16 → $14 | Strong Buy | Maintains | $16 → $14 | +288.89% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +233.33% | Aug 11, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $16 | Strong Buy | Maintains | $13 → $16 | +344.44% | Jun 10, 2025 |
| Roth Capital | Roth Capital | Strong Buy Maintains $10 → $23 | Strong Buy | Maintains | $10 → $23 | +538.89% | Jun 6, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +261.11% | May 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +205.56% | Apr 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +205.56% | Mar 31, 2025 |